Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UniSyn Molecular Imaging (6-3-1)

K-Number: K231047 · 2023-09-01

Decision Date2023-09-01
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

UniSyn Molecular Imaging (6-3-1) is the device name listed in this FDA 510(k) record. The listed applicant is Convergent Imaging Solutions. It received FDA 510(k) clearance on 2023-09-01 under 510(k) number K231047. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UniSyn Molecular Imaging (6-3-1)?

UniSyn Molecular Imaging (6-3-1) is a medical device that received FDA 510(k) clearance on 2023-09-01. The listed applicant is Convergent Imaging Solutions. The 510(k) number is K231047.

When did UniSyn Molecular Imaging (6-3-1) receive FDA 510(k) clearance?

UniSyn Molecular Imaging (6-3-1) received FDA 510(k) clearance on 2023-09-01, under 510(k) number K231047.

Who is the listed applicant for UniSyn Molecular Imaging (6-3-1)?

The FDA 510(k) record lists Convergent Imaging Solutions as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for UniSyn Molecular Imaging (6-3-1)?

The FDA product code for UniSyn Molecular Imaging (6-3-1) is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.